German pharma business Bayer goes live with SunGard
Latest news
German pharma business Bayer goes live with SunGard 07 May 2013Germany Reporter: Georgina Lavers
Image: Shutterstock
The German chemical and pharmaceutical company Bayer has gone live with SunGard’s Adaptiv solutions for risk management.
Adaptiv Analytics, Adaptiv 360 and Adaptiv Operations will all aim to help Bayer in conducting fast Monte Carlo-based calculations of risk measures such as value at risk (VaR), potential future exposure (PFE), credit valuation adjustment (CVA), and debt valuation adjustment (DVA).
By doing this, SunGard hopes to support the firm’s global financial risk management, treasury operations from trading to hedge accounting, and adherence to the International Financial Reporting Standards (IFRS) 13 rules.
Juerg Hunziker, president of trading and risk for SunGard’s capital markets business said: “With SunGard’s Adaptiv, Bayer can focus on utilizing advanced risk management and calculation methodologies to help mitigate risk and comply with the latest regulatory requirements.
"Quickly and accurately calculating risk measures such as CVA, DVA, PFE and VaR across an enterprise will help firms to be well-positioned to gain a competitive advantage in industries where new regulations like IFRS 13 demand new or improved approaches to managing risk.”
NO FEE, NO RISK 100% ON RETURNSIf you invest in only one asset servicing news source this
year, make sure it is your free subscription to Asset Servicing Times
Image: Shutterstock 